The proposed hypotheses underlining excessive adiposity and gastrointestinal cancer risks include altered insulin and IGF-1 signaling, chronic low-grade inflammation associated with obesity, and disruptions in sex hormone metabolism. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.